Home β€Ί Stock analysis β€Ί PLRZ

Polyrizon (PLRZ) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

PLRZ ends flat (-0.1%) to $10.00. Closed at $10.00, -0.10% vs the prior close of $10.01. Day range $9.00–$10.00, opened at $10.00.

Last close$10.00-0.10%
Day range9.00–10.00
Open10.00
Volume19.25K
52-week range2.88–18.20
Avg volume (20d)23.79K

PLRZ daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” PLRZ ends flat (-0.1%) to $10.00
Oct 15, 2026 β€” PLRZ slides 3.8% to $10.01
Oct 14, 2026 β€” PLRZ jumps 6.9% to $10.41, 4 up days in a row
Oct 13, 2026 β€” PLRZ jumps 7.6% to $9.74, 3 up days in a row
Oct 12, 2026 β€” PLRZ rises 0.7% to $9.05
Oct 9, 2026 β€” PLRZ rises 1.3% to $8.99
Oct 8, 2026 β€” PLRZ slides 3.1% to $8.87, a 6-month low
Oct 7, 2026 β€” PLRZ slides 5.4% to $9.15, a 6-month low
Oct 6, 2026 β€” PLRZ jumps 4.4% to $9.67
Oct 5, 2026 β€” PLRZ slides 3.6% to $9.26, a 6-month low, 3 down days in a row
Oct 2, 2026 β€” PLRZ slides 6.9% to $9.61, a 6-month low

PLRZ latest news & SEC filings

Every SEC filing by or about PLRZ in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 7, 2026 Β· Form S-8 β€” Employee share plan registration

Registration of shares for employee stock plans (S-8)

Source: SEC EDGAR filing 0001213900-26-107582

Oct 5, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-106814

Oct 1, 2026 Β· Form EFFECT β€” EFFECT filing

EFFECT filing

Source: SEC EDGAR filing 9999999995-26-003133

Sep 28, 2026 Β· Form F-1/A β€” F-1/A filing

F-1/A filing

Source: SEC EDGAR filing 0001213900-26-104062

Sep 28, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-104045

Sep 18, 2026 Β· Form F-1 β€” F-1 filing

F-1 filing

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001213900-26-101441

Sep 10, 2026 Β· Form D β€” D filing

D filing

Source: SEC EDGAR filing 0001213900-26-098803

Sep 4, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-097696

Sep 4, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-097444

Sep 4, 2026 Β· Form 424B5 β€” Prospectus supplement

Prospectus supplement β€” the company is selling securities off a shelf registration

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001213900-26-097441

Aug 20, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-092083

Aug 14, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000912282-26-001117

Jul 13, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-077540

Jul 2, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-074946

Jun 29, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001213900-26-073097

Things to know before you trade PLRZ

PLRZ market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 202610.0010.009.0010.0019.25K
Oct 15, 202610.3110.689.8010.0173.30K
Oct 14, 202610.0911.589.5410.4190.20K
Oct 13, 20269.1610.008.009.7447.00K
Oct 12, 20269.059.148.769.056.40K
Oct 9, 20268.679.518.228.9940.10K
Oct 8, 20269.319.318.708.8710.30K
Oct 7, 20269.279.279.009.155.10K
Oct 6, 20269.509.679.269.676.20K
Oct 5, 20269.489.889.139.2617.00K
Oct 2, 202610.5610.879.159.6156.50K
Oct 1, 202610.3010.4810.1610.322.00K
Sep 30, 202610.3910.8710.0810.7813.50K
Sep 29, 202610.6111.0010.3610.498.70K
Sep 28, 202610.5010.7610.3610.364.50K
Sep 25, 202610.5010.7710.5010.771.00K
Sep 24, 202610.9311.3510.5010.5113.40K
Sep 23, 202610.6211.9910.0911.1640.10K
Sep 22, 202611.0311.0310.5010.666.50K
Sep 21, 202611.0011.0010.5510.9014.80K

About Polyrizon

Polyrizon (PLRZ) is listed on the Nasdaq and classified by the SEC under β€œSurgical & Medical Instruments & Apparatus”. Its business address is in RA'ANANA. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1893645.

PLRZ board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Oz AdlerDirectorApr 1, 2026
Liron CarmelDirectorApr 1, 2026
Asaf ItzhaikDirectorMar 18, 2026
Tomer IzraeliChief Executive OfficerApr 1, 2026
Liat SidiDirectorMar 18, 2026
Tidhar TurgemanChief Technology OfficerMar 31, 2026
Yehonatan Zalman VinokurDirectorMar 18, 2026

Executive officers

NameTitleLatest filing
Nir BenyosefChief Financial OfficerMar 18, 2026
Tomer IzraeliChief Executive OfficerApr 1, 2026
Eyal S RonChief Science OfficerMar 18, 2026
Tidhar TurgemanChief Technology OfficerMar 31, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Mar 31, 2026Liron CarmelSale942$12.36
Mar 31, 2026Liron CarmelSale942$12.36
Mar 31, 2026Liron CarmelSale942$12.36
Mar 31, 2026Liron CarmelSale942$12.36
Mar 31, 2026Oz AdlerSale3,292$12.05
Mar 31, 2026Oz AdlerSale3,292$12.05
Mar 31, 2026Oz AdlerSale3,292$12.05
Mar 31, 2026Oz AdlerSale3,292$12.05
Mar 31, 2026Tomer IzraeliSale500$11.85
Mar 31, 2026Tomer IzraeliSale500$11.85
Mar 31, 2026Tomer IzraeliSale500$11.85
Mar 31, 2026Tomer IzraeliSale500$11.85
Mar 30, 2026Liron CarmelSale100$11.00
Mar 30, 2026Liron CarmelSale100$11.00
Mar 30, 2026Liron CarmelSale100$11.00

PLRZ financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

PLRZ earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Surgical & Medical Instruments & Apparatus

Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)MiniMed (MMED)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on PLRZ

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.